Compare FMC Corp (FMC) vs Marvell Technology Inc (MRVL) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Marvell Technology (MRVL) trades at $187.77, down 15.59% in the past 24 hours, reflecting recent market volatility. The stock shows strong analyst support with an 82.19% buy rating and a consensus price target of $275.68. Recent earnings beats and projected revenue growth to $8.7B in 2026 highlight fundamental strength, though high valuation ratios like a P/E of 70.88 and negative net income in 2025 pose concerns. Technical indicators are mixed, with oscillators bullish but moving averages bearish, and key support at $183.

The outlook for MRVL is cautiously optimistic, driven by AI infrastructure demand and custom chip growth opportunities. Risks include competitive pressures, execution challenges, and high debt levels. Investors should weigh the strong analyst consensus against valuation premiums and near-term profitability concerns.